Stockholders' Equity - Narrative (Details)			3 Months Ended		182 Months Ended
	Aug. 27, 2024 USD ($)	Mar. 27, 2024 USD ($) $ / shares shares	Mar. 31, 2025 USD ($) period $ / shares shares	Mar. 31, 2024 USD ($) $ / shares shares	Mar. 31, 2025 USD ($) period $ / shares shares	Dec. 31, 2024 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares) | shares			400,000,000		400,000,000	400,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.01		$ 0.01	$ 0.01
Preferred stock, authorized (in shares) | shares			100,000,000		100,000,000
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.01		$ 0.01
Number of shares issued (in shares) | shares			3,506,371
Weighted average offering price (in dollars per share) | $ / shares			$ 67.71	$ 64.00
Issuance of common stock (in shares) | shares				2,353,278
Underwriting discount and offering costs			$ 4,041,000	$ 3,226,000
Shares repurchase program, authorized repurchase amount (in shares) | shares			3,000,000		3,000,000
Withdraw from deferred compensation plan (in shares) | shares			0	0
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares			$ 65.80
Fair value of the restricted stock granted			$ 4,200,000
Unrecognized compensation costs related to restricted stock issuances			$ 17,700,000		$ 17,700,000
Remaining weighted average period (years)			2 years 10 months 24 days
Expense			$ 1,900,000	$ 1,400,000
Minimum | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares					$ 14.20
Vesting period for the restricted stock (years)			3 years
Maximum | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares					$ 78.33
Vesting period for the restricted stock (years)			5 years
2019 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares) | shares			1,898,961		1,898,961
Remaining balance of shares available (in shares) | shares			258,368		258,368
Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares			41,192
Shares issued, price per share (in dollars per share) | $ / shares			$ 58.51		$ 58.51
Number of measurement periods | period			3		3
Common Shares Held in Deferred Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award
Deposits to deferred compensation plan (in shares) | shares			36,233	0
$500 Million ATM Program
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price			$ 500,000,000
Common stock remaining offering price			200,800,000		$ 200,800,000
Net proceeds form offerings			234,000,000.0
Total compensation to the applicable sales agents			$ 3,400,000
Previous At Market Equity Offering Program 500 Million
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price	$ 500,000,000
Net proceeds form offerings				$ 148,400,000
Total compensation to the applicable sales agents				$ 2,200,000
IPO | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares		6,325,000
Net proceeds form offerings		$ 387,100,000
Shares issued, price per share (in dollars per share) | $ / shares		$ 62.00
Underwriting discount and offering costs		$ 5,000,000
Over-Allotment Option | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares		825,000